2nd Place — UIUC SymposiumIndependent Researcher — UChicago Lab
＋
Add media
Images, video, GIFs — drag or click
Image / Video
Image / Video
About this project
A 300+ hour wetlab immunology project evaluating small molecule inhibition of TET2 as a strategy to overcome adaptive resistance to radiation therapy in cancer cells. Conducted at the University of Chicago. Presented at the University of Illinois, Urbana-Champaign cancer research symposium in front of faculty from top Illinois universities.
Key highlights
Cultured CT-26 cell lines to test drug effects on radiation-resistant cells
Evaluated TET2 inhibition for overcoming adaptive radiation resistance
Awarded 2nd place out of 36 presenters at the UIUC symposium
Project inspired a subsequent grant-winning study by a fellow lab member